ES2982316T3 - Uso de un compuesto de carbamato para prevenir, aliviar o tratar las crisis de ausencia o la epilepsia que muestra crisis de ausencia - Google Patents
Uso de un compuesto de carbamato para prevenir, aliviar o tratar las crisis de ausencia o la epilepsia que muestra crisis de ausencia Download PDFInfo
- Publication number
- ES2982316T3 ES2982316T3 ES18878222T ES18878222T ES2982316T3 ES 2982316 T3 ES2982316 T3 ES 2982316T3 ES 18878222 T ES18878222 T ES 18878222T ES 18878222 T ES18878222 T ES 18878222T ES 2982316 T3 ES2982316 T3 ES 2982316T3
- Authority
- ES
- Spain
- Prior art keywords
- absence
- epilepsy
- seizures
- use according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20170151248 | 2017-11-14 | ||
| PCT/KR2018/013761 WO2019098628A1 (ko) | 2017-11-14 | 2018-11-13 | 결신 발작 또는 결신 발작을 나타내는 뇌전증의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2982316T3 true ES2982316T3 (es) | 2024-10-15 |
Family
ID=66540315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18878222T Active ES2982316T3 (es) | 2017-11-14 | 2018-11-13 | Uso de un compuesto de carbamato para prevenir, aliviar o tratar las crisis de ausencia o la epilepsia que muestra crisis de ausencia |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20200352907A1 (enExample) |
| EP (1) | EP3711758B1 (enExample) |
| JP (2) | JP7258901B2 (enExample) |
| KR (1) | KR102739584B1 (enExample) |
| CN (1) | CN111432812A (enExample) |
| AU (1) | AU2018367729B2 (enExample) |
| BR (1) | BR112020009265A2 (enExample) |
| CA (1) | CA3081223A1 (enExample) |
| DK (1) | DK3711758T3 (enExample) |
| ES (1) | ES2982316T3 (enExample) |
| FI (1) | FI3711758T3 (enExample) |
| IL (1) | IL274428B2 (enExample) |
| MX (1) | MX2020004972A (enExample) |
| PL (1) | PL3711758T3 (enExample) |
| PT (1) | PT3711758T (enExample) |
| WO (1) | WO2019098628A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12070448B2 (en) * | 2018-09-21 | 2024-08-27 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for prevention, alleviation or treatment of status epilepticus |
| CN116143717B (zh) * | 2021-11-22 | 2025-05-06 | 康百达（四川）生物医药科技有限公司 | 一种氘代氨基甲酸酯化合物及其在医药上的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6383764B1 (en) | 2000-04-28 | 2002-05-07 | The Regents Of The University Of California | Methods of identifying compounds for controlling absence seizures in a mammal relating to prolactin-releasing peptide(PrRP) |
| KR100534556B1 (ko) | 2001-10-26 | 2005-12-08 | 주식회사 오리엔트바이오 | 알파１ｇ 단백질의 기능을 억제하여 간질을 일으키지 않게하는 방법 |
| EP1707204A1 (en) * | 2005-04-01 | 2006-10-04 | Bioprojet | Treatment of epilepsy with non-imidazole alkylamines histamine H3-receptor ligands |
| US7598279B2 (en) | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| CN102803233B (zh) * | 2009-06-22 | 2017-03-01 | 爱思开生物制药株式会社 | 制备氨基甲酸(r)‑1‑芳基‑2‑四唑基‑乙酯的方法 |
| US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| US9629853B2 (en) | 2014-05-21 | 2017-04-25 | Wisconsin Alumni Research Foundation | Uses of ganaxolone |
| KR102489052B1 (ko) | 2016-05-19 | 2023-01-16 | 에스케이바이오팜 주식회사 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
| AU2017374450B2 (en) | 2016-12-14 | 2023-05-11 | Sk Biopharmaceuticals Co., Ltd. | Parenteral liquid preparation comprising carbamate compound |
| CN111065394B (zh) | 2017-08-31 | 2023-03-31 | 武田药品工业株式会社 | 中枢神经系统病症的治疗 |
-
2018
- 2018-11-13 WO PCT/KR2018/013761 patent/WO2019098628A1/ko not_active Ceased
- 2018-11-13 EP EP18878222.1A patent/EP3711758B1/en active Active
- 2018-11-13 PT PT188782221T patent/PT3711758T/pt unknown
- 2018-11-13 PL PL18878222.1T patent/PL3711758T3/pl unknown
- 2018-11-13 AU AU2018367729A patent/AU2018367729B2/en active Active
- 2018-11-13 MX MX2020004972A patent/MX2020004972A/es unknown
- 2018-11-13 CA CA3081223A patent/CA3081223A1/en active Pending
- 2018-11-13 DK DK18878222.1T patent/DK3711758T3/da active
- 2018-11-13 US US16/763,636 patent/US20200352907A1/en active Pending
- 2018-11-13 JP JP2020544727A patent/JP7258901B2/ja active Active
- 2018-11-13 FI FIEP18878222.1T patent/FI3711758T3/fi active
- 2018-11-13 CN CN201880073833.7A patent/CN111432812A/zh active Pending
- 2018-11-13 KR KR1020207013843A patent/KR102739584B1/ko active Active
- 2018-11-13 BR BR112020009265-7A patent/BR112020009265A2/pt unknown
- 2018-11-13 ES ES18878222T patent/ES2982316T3/es active Active
-
2020
- 2020-05-04 IL IL274428A patent/IL274428B2/en unknown
-
2023
- 2023-04-05 JP JP2023061633A patent/JP7578747B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3711758A4 (en) | 2021-08-04 |
| AU2018367729A1 (en) | 2020-05-21 |
| WO2019098628A1 (ko) | 2019-05-23 |
| RU2020119292A3 (enExample) | 2022-02-24 |
| PL3711758T3 (pl) | 2024-07-01 |
| US20200352907A1 (en) | 2020-11-12 |
| IL274428B1 (en) | 2023-04-01 |
| KR102739584B1 (ko) | 2024-12-06 |
| JP2021503010A (ja) | 2021-02-04 |
| EP3711758A1 (en) | 2020-09-23 |
| JP2023085469A (ja) | 2023-06-20 |
| CA3081223A1 (en) | 2019-05-23 |
| DK3711758T3 (da) | 2024-04-08 |
| IL274428A (en) | 2020-06-30 |
| IL274428B2 (en) | 2023-08-01 |
| CN111432812A (zh) | 2020-07-17 |
| AU2018367729B2 (en) | 2024-06-13 |
| JP7258901B2 (ja) | 2023-04-17 |
| PT3711758T (pt) | 2024-04-22 |
| MX2020004972A (es) | 2020-08-24 |
| BR112020009265A2 (pt) | 2020-10-20 |
| JP7578747B2 (ja) | 2024-11-06 |
| KR20200074153A (ko) | 2020-06-24 |
| EP3711758B1 (en) | 2024-03-27 |
| RU2020119292A (ru) | 2021-12-15 |
| FI3711758T3 (fi) | 2024-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7588675B2 (ja) | 脆弱ｘ症候群、アンジェルマン症候群又はレット症候群を含む発達障害の軽減又は治療のためのカルバメート化合物の使用 | |
| JP7578747B2 (ja) | 欠神発作又は欠神発作を示すてんかんの予防、軽減又は治療のためのカルバメート化合物の使用 | |
| ES2887338T3 (es) | Uso de un compuesto de carbamato para prevenir o tratar la neuralgia del trigémino | |
| EP3556366B1 (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| JP7417595B2 (ja) | てんかん重積状態の予防、軽減又は治療のためのカルバメート化合物の使用 | |
| ES2656905T3 (es) | Agente para mejorar la disinergia vesicouretral | |
| RU2787771C2 (ru) | Применение карбаматного производного для предотвращения, облегчения или лечения малого эпилептического припадка или эпилепсии, проявляющей малый эпилептический припадок | |
| EP3854391B1 (en) | Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder | |
| ES2975254T3 (es) | Uso de compuestos de carbamato para la prevención, alivio o tratamiento del prurito | |
| RU2774970C2 (ru) | Применение карбаматных соединений для профилактики, облегчения или лечения биполярного расстройства | |
| RU2793742C2 (ru) | Применение карбаматного соединения для снижения или лечения нарушений развития, включая синдром хрупкой x-хромосомы, синдром ангельмана или синдром ретта | |
| TW202515540A (zh) | 使用三重再攝取抑制劑治療睡眠障礙之方法 | |
| HK40015213A (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder |